Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects

被引:0
|
作者
Vitek, Grace [1 ]
Hansra, Harjot [2 ]
机构
[1] Creighton Univ, Sch Med, Omaha, NE USA
[2] Dignity Hlth, Barrow Neurol Inst, San Francisco, CA USA
关键词
D O I
10.1212/WNL.0000000000203811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P5-4.001
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy
    Owen, C. N.
    Bai, X.
    Quah, T.
    Lo, S.
    Callaghan, S.
    Martinez-Vila, C.
    Bhave, P.
    Reijers, I.
    Gerard, C. L.
    Aspelagh, S.
    Xu, W.
    Welsh, S. J.
    Sandhu, S.
    Mangana, J.
    McQuade, J. L.
    Ascierto, P. A.
    Zimmer, L.
    Johnson, D. B.
    Lebbe, C.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S761 - S762
  • [32] Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm
    Argentiero, Antonella
    Solimando, Antonio Giovanni
    Ungaro, Valentina
    Laforgia, Mariarita
    Strippoli, Sabino
    Pinto, Dario
    Negri, Antonio
    Ferraiuolo, Simona
    Zito, Alfredo
    Guida, Michele
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
    Sebestyen, Eniko
    Major, Nora
    Bodoki, Levente
    Makai, Attila
    Balogh, Ingrid
    Toth, Gabor
    Orosz, Zsuzsanna
    Arkosy, Peter
    Vasko, Attila
    Hodosi, Katalin
    Szekanecz, Zoltan
    Szekanecz, Eva
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [34] CUTANEOUS IMMUNE-RELATED ADVERSE EVENTS ARE PROTECTIVE OF MORTALITY IN PATIENTS TREATED WITH ANTI-PD1 AND ANTI-PDL1 THERAPY IN A MULTI-INSTITUTIONAL COHORT STUDY
    Semenov, Yevgeniy
    Tang, Kimberly
    Seo, Jayhyun
    Reynolds, Kerry
    Tiu, Bruce
    Le, Thomas
    Pahalyants, Vartan
    Raval, Neel
    Ugwu-Dike, Pearl
    Zubiri, Leyre
    Naranbhai, Vivek
    Gusev, Alexander
    LeBoeuf, Nicole
    Asgari, Maryam
    Kwatra, Shawn
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A850 - A851
  • [35] Immunological features of immune-related adverse events during anti-PD-1/PD-L1 immune checkpoint inhibition
    Goswami, Meghali
    Gui, Gege
    Lindblad, Katherine
    Del Rivero, Jaydira
    Marte, Jennifer
    Dagur, Pradeep
    Destefano, Christin
    Thompson, Julie
    Popescu, Bogdan
    Dillon, Laura
    Johnson, Cheryl
    Soldin, Steven
    Lai, Catherine
    Gulley, James
    Hourigan, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [36] Two cases of granuloma annulare under anti-PD1 therapy
    Charollais, R.
    Aubin, F.
    Roche-Kubler, B.
    Puzenat, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (02): : 116 - 119
  • [37] Safety assessment of anti-PD(L)1 rechallenge after immune-related adverse events
    Simonaggio
    Michot, J. -M.
    Champiat, S.
    Vozy, A.
    Lapera, A.
    Marabelle, A.
    Le Pavec, J.
    Voisin, A. -L.
    Lallart, A.
    Cengizalp, G.
    Lambotte, O.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
    Suo, Aleksi
    Chan, Yin
    Beaulieu, Carissa
    Kong, Shiying
    Cheung, Winson Y.
    Monzon, Jose G.
    Smylie, Michael
    Walker, John
    Morris, Don
    Cheng, Tina
    ONCOLOGIST, 2020, 25 (05): : 438 - 446
  • [39] Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
    De Lorenzo, Sotiria Stavropoulou
    Andravizou, Athina
    Alexopoulos, Harry
    Michailidou, Iliana
    Bokas, Alexandros
    Kesidou, Evangelia
    Boziki, Marina-Kleopatra
    Parissis, Dimitrios
    Bakirtzis, Christos
    Grigoriadis, Nikolaos
    BIOMEDICINES, 2024, 12 (06)
  • [40] Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1)
    Cybulska-Stopa, Bozena
    Kaminska-Winciorek, Grazyna
    Dyduch, Grzegorz
    MELANOMA RESEARCH, 2020, 30 (06) : 619 - 624